Preventing HIV with Pre-Exposure Medication:
What Texas Health Steps Providers Should Know

Taking PrEP (pre-exposure prophylaxis) medication as prescribed reduces the risk of getting HIV via sexual contact by about 99% and reduces the risk of getting HIV by at least 74% among persons who inject drugs.

Centers for Disease Control and Prevention (2021)

Choose any section below to learn more.

The HIV Epidemic in the U.S.

What is PrEP?

Who Should Take PrEP and For How Long?

The Role of Health-Care Providers

Resources

• Appendix of Resources

  American Academy of Pediatrics. (2022). Clinical Report: Adolescents and Young Adults: The Pediatrician’s Role in HIV Testing and Pre- and Postexposure HIV Prophylaxis. Pediatrics, 149(1):e2021055207.

  Centers for Disease Control and Prevention PrEP Guidelines. (2021). Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2021 Update – A Clinical Practice Guideline.

  Centers for Disease Control and Prevention, National Prevention Information Network. Using the advanced search filters, locate PrEP providers in or close to your ZIP code.

  Centers for Disease Control and Prevention PEP guidelines. (2020). HIV: Post-Exposure Prophylaxis resources web page.

  Centers for Disease Control and Prevention’s interactive map showing HIV cases by Texas county.

  Centers for Disease Control and Prevention, resources for Youth HIV Prevention and National Youth HIV/AIDS Awareness Day.

  Contemporary Pediatrics. (2014). HEEADSSS screening tool.

  National Coalition for Sexual Health. Essential Sexual Health Questions to Ask Adolescents.

  National Institute of Allergy and Infectious Diseases. (2020). NIAID HIV Language Guide.

  PleasePrEPme.org. Find a (PrEP) Provider by searching by ZIP code.

  Texas Department of State Health Services. (2021). PrEP Providers in Texas.

  Texas Health Steps. Anticipatory Guidance Provider Guide.

  Texas Health Steps. Periodicity Schedule.

• References Featured in Course

  American Academy of Pediatrics. (2022). Clinical Report: Adolescents and Young Adults: The Pediatrician’s Role in HIV Testing and Pre- and Postexposure HIV Prophylaxis. Pediatrics, 149(1):e2021055207.

  Centers for Disease Control and Prevention, U.S. Public Health Service. (2022). HIV: Pre-exposure Prophylaxis (PrEP).

  Centers for Disease Control and Prevention, U.S. Public Health Service. (2021). Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2021 Update – A Clinical Practice Guideline.

  Centers for Disease Control and Prevention, U.S. Public Health Service. (2021). HIV Pre-exposure Prophylaxis (PrEP) Care System.

  Centers for Disease Control and Prevention. (2021). About HIV.

  Centers for Disease Control and Prevention. (2021). HIV Treatment.

  Centers for Disease Control and Prevention. (2021). HIV in the United States and Dependent Areas.

  Centers for Disease Control and Prevention. (2019). Issue Brief: HIV in the Southern United States.

  Centers for Disease Control and Prevention. (n.d.). Interactive Texas map showing counties with new HIV cases in 2019 among ages 13 years and older.

  Centers for Disease Control and Prevention. (2021). PrEP Effectiveness.

  Centers for Disease Control and Prevention. (2021). Starting and Stopping PrEP.

  Centers for Disease Control and Prevention. (2021). Estimated Annual Number of HIV Infections—United States, 1981-2019. Morbidity and Mortality Weekly Report (MMWR), 70(22);801–806.

  Centers for Disease Control and Prevention. (2020). HIV: Post-Exposure Prophylaxis resources web page.

  Centers for Disease Control and Prevention. (2020). Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations. Morbidity and Mortality Weekly Report (MMWR), 69(RR-3):1–12.

  Centers for Disease Control and Prevention. (2020). Sexual Transmission and Viral Hepatitis.

  Centers for Disease Control and Prevention. (2019). HIV Testing in 50 Local Jurisdictions Accounting for the Majority of New HIV Diagnoses and Seven States with Disproportionate Occurrence of HIV in Rural Areas, 2016–2017. Morbidity and Mortality Weekly Report (MMWR), 68:561–567.

  Hosek, S., & Henry-Reid, L. (2020). State of the Art Review: PrEP and Adolescents: The Role of Providers in Ending the AIDS Epidemic. Pediatrics, 145(1): e20191743.

  National Institute of Allergy and Infectious Diseases. (2020). NIAID HIV Language Guide.

  Texas Department of State Health Services. (2021). POPS Chapter 22 - Pre-Exposure Prophylaxis (PrEP) and Non-occupational Post-Exposure Prophylaxis (nPEP).

  Texas Department of State Health Services. (2021). Pre-Exposure Prophylaxis (PrEP).

  Texas Department of State Health Services. (2021). Texas HIV Surveillance Report 2019 Annual Report.

  Texas Health Steps. Periodicity Schedule.

  U.S. Department of Health and Human Services, HIV.gov. (2021). About Ending the HIV Epidemic in the U.S.: Key Strategies in the Plan.

  U.S. Department of Health and Human Services, HIV.gov. (2021). Overview: What is Ending the HIV Epidemic in the U.S.? 

  U.S. Department of Health and Human Services, HIV.gov. (2021). HIV Prevention: Post-Exposure Prophylaxis (PEP).

  U.S. Department of Health and Human Services, HIV.gov. (2021). HIV Basics: U.S. Statistics, Fast Facts.

  U.S. Department of Health and Human Services, Office of Infectious Disease and HIV/AIDS Policy. (2021). Ready, Set, Prep.

  U.S. Department of Health and Human Services, HIV.gov. (2019). HIV Blog: Too Many People in the U.S. Living with HIV Don’t Know It.

  U.S. Food and Drug Administration. (2021). FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention.